| Literature DB >> 26902626 |
Michael Kongnyuy1, Arvin K George2, Ardeshir R Rastinehad3, Peter A Pinto4.
Abstract
Transrectal ultrasound (TRUS)-guided (12-14 core) systematic biopsy of the prostate is the recommended standard for patients with suspicion of prostate cancer (PCa). Advances in imaging have led to the application of magnetic resonance imaging (MRI) for the detection of PCa with subsequent development of software-based co-registration allowing for the integration of MRI with real-time TRUS during prostate biopsy. A number of fusion-guided methods and platforms are now commercially available with common elements in image and analysis and planning. Implementation of fusion-guided prostate biopsy has now been proven to improve the detection of clinically significant PCa in appropriately selected patients.Entities:
Keywords: Biopsy; Magnetic resonance imaging; Prostate cancer; Transrectal ultrasound
Mesh:
Year: 2016 PMID: 26902626 PMCID: PMC4928379 DOI: 10.1007/s11934-016-0589-z
Source DB: PubMed Journal: Curr Urol Rep ISSN: 1527-2737 Impact factor: 3.092